Orbimed Advisors LLC Repare Therapeutics Inc. Transaction History
Orbimed Advisors LLC
- $4.44 Billion
- Q1 2024
A detailed history of Orbimed Advisors LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 3,322,488 shares of RPTX stock, worth $11 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
3,322,488
Previous 3,322,488
-0.0%
Holding current value
$11 Million
Previous $24.3 Million
35.48%
% of portfolio
0.35%
Previous 0.59%
Shares
2 transactions
Others Institutions Holding RPTX
# of Institutions
78Shares Held
38.5MCall Options Held
66.4KPut Options Held
2.7K-
Bvf Inc San Francisco, CA10.3MShares$34.1 Million1.46% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.12MShares$10.3 Million3.9% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$9.79 Million17.66% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.7MShares$8.92 Million0.09% of portfolio
-
Deep Track Capital, LP Greenwich, CT2.68MShares$8.86 Million0.42% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $138M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...